The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

BPH Global (ASX:BP8) has this week signed a significant seaweed offtake agreement with Quanzhou Bailijie Biotechnology, a Chinese carrageenan producer.

Listen to the HotCopper podcast for in-depth discussions and insights on all the biggest headlines from throughout the week. On Spotify, Apple, and more.

The deal revolves around the monthly sale of BPH’s raw seaweed products, with 100 metric tons of high-quality Eucheuma cottonii seaweed to now be shipped to Quanzhou. That will then expand to as much as 500 tons by 2027.

“We’ve been so impressed with the factories in China,” BP8 CEO Matthew Leonard said, speaking to HotCopper on the major deal heading into Week 16.

“BPH Global is very happy about this two-year agreement – it’s a significant offtake agreement. That potential to scale up to 500 tons a month [is exciting] and we’re really looking forward to working with this great client now.”

Mr Leonard added the plan now is to “grow up” through the two-year deal.

BP8 has been trading relatively flat today and sits at 0.3cps.

Join the discussion. See what HotCopper users are saying about BPH Global and be part of the conversations that move the markets.

The material provided in this article is for information only and should not be treated as investment advice. Viewers are encouraged to conduct their own research and consult with a certified financial advisor before making any investment decisions. For full disclaimer information, please click here.

bp8 by the numbers
More From The Market Online
US flag

Dateline Resources pops +40% on Trump gov’t move to greenlight REE and gold mining

An injunction on ASX-listed Dateline Resources’ (ASX:DTR) California-based Colosseum REE and gold project appears set to be lifted after
The ASX Today feature image with a blue Australia silhouette (STOCK) beside The Market Link column branding.

ASX Today: XJO has a good day ahead of RBA rate call; AU bond sell-off continues

While we’re set to get the RBA’s next rate decision tomorrow – which all big bank analysts think is going to be a
Aussie cash

Northern Star jumps +7% on confirmed takeover rumour from Gold Fields Ltd

ASX-listed Northern Star Resources (ASX:NST) has confirmed reports in Bloomberg that it’s received a 100% takeover offer from a

AFT Pharmaceuticals opens Japan opportunity for Maxigesic IV

AFT Pharmaceuticals (ASX: AFP) has secured an exclusive development, licensing and supply agreement for its Maxigesic® IV (also known as Combogesic® IV)